Shanghai, China

Jing Al

This inventor holds 1 USPTO granted patent. Top assignees: Chinese Academy of Sciences, Shanghai Haihe Pharmaceutical Co., Ltd.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jing Al. Retrieved from https://idiyas.com/inventor/jing-al

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jing Al: Innovator in Pharmaceutical Chemistry

Introduction

Jing Al is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pyridine compounds. His research focuses on developing new methods for producing compounds that can be used in medical applications.

Latest Patents

Jing Al holds a patent for "Five-member-heterocycle fused pyridine compounds, method of producing the same, and use thereof." This invention provides a class of five-member-heterocycle fused pyridine compounds, along with pharmaceutically acceptable salts or solvates. The patent outlines a method for producing these compounds and discusses their use in pharmaceutical compositions aimed at preventing and treating diseases and tumors associated with abnormal protein tyrosine kinase. He has 1 patent to his name.

Career Highlights

Throughout his career, Jing Al has worked with esteemed organizations such as the Chinese Academy of Sciences and Shanghai Haihe Pharmaceutical Co., Ltd. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Jingkang Shen and Meiyu Geng. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.

Conclusion

Jing Al's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions to the development of new compounds hold promise for improving medical treatments and addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…